2128
D. Wang et al. / Journal of Organometallic Chemistry 689 (2004) 2123–2130
3.1. ZnCl2(NHC) (1)
J ¼ 7:60), 7.17 (2H, s), 6.65 (4H, s), 2.11 (12H, s), 1.79
(6H, s); 13C NMR (CDCl3) d 177.07, 173.55, 139.85,
135.04, 133.57, 130.71, 129.06, 127.15, 123.10, 20.61,
17.40. Anal. Calc. for C35H34N2O4Zn: C, 68.68; H, 5.60;
N, 4.58. Found: C, 68.69; H, 5.96; N, 4.33%. MS (FAB):
m=z calc. for C35H34N2O4Zn: 610.18, found
m=z ¼ 1130:8 (C63H64N5O7Zn2, 20%).
ZnCl2 (136.3 mg, 1.000 mmol) was dissolved in 15 ml
of THF and a solution of 1,3-bis(2,4,6-trimethylphenyl)-
imidazol-2-ylidene (303.4 mg, 1.000 mmol) in 3 ml of
THF was added slowly. The mixture was stirred at room
temperature for 12 h. The resulting solution was then
concentrated to ꢂ5 ml. After the addition of 20 ml of
pentane, a white solid precipitated, which was filtered off
and washed three times with pentane, and dried in va-
cuo. Yield: 350.2 mg (80%). A crystal of 1 suitable for X-
ray analysis was obtained by cooling a concentrated
THF solution to )40 °C for several days. FT-IR (ATR-
3.4. [Zn(OCOCH2Ph)2(NHC)]2 (4)
Zn(OCOCH2Ph)2 (100.0 mg, 0.298 mmol, prepared
by the reaction of ZnEt2 and PhCH2COOH in THF and
used without further purification) was suspended in 10
ml of THF, then a solution of 1,3-bis(2,4,6-trimethyl-
phenyl)-imidazol-2-ylidene (90.5 mg, 0.299 mmol) in 2
ml of THF was added. After 20 min of stirring, the
precipitate had dissolved. The mixture was stirred
overnight, and was then concentrated to 5 ml. Ten
milliliters of pentane was added, resulting in the for-
mation of a white solid, which was filtered off, washed
with pentane, and dried in vacuo. Yield: 160 mg (84%).
Crystals of 4 were obtained by slowly cooling a con-
centrated THF solution of the complex. FT-IR (ATR-
mode, cmꢁ1): 3025m, 2916m, 1586s, 1487m, 1366w,
850m; 1H NMR (CDCl3) d 7.32–6.63 (16H, m), 3.15
(4H, s), 2.35–1.74 (18H, m); 13C NMR (THF-d8) d
182.51, 143.83, 141.03, 140.38, 140.32, 134.89, 134.62,
134.06, 132.68, 130.81, 130.38, 128.66, 48.34, 25.78,
22.25; MS calc. for C74H76N4O8Zn2 1276.42, found
1162.56 ([(M+H)-PhCH2CO]þ), 1145.57 ([(M+H)-
PhCH2COOH]þ).
mode, cmꢁ1): 3030m, 2920m, 1600m, 1550s, 1482w; H
1
NMR (CDCl3) d 7.02 (2H, s), 6.89 (4H, s), 2.30 (6H, s),
2.03 (12H, s). 13C NMR (CDCl3) d 172.98, 139.22,
135.45, 133.79, 129.06, 122.90, 21.11, 17.76. Anal. Calc.
for C21H24N2Cl2Zn: C, 57.23; H, 5.49; N, 6.39. Found:
C, 56.99; H, 5.39; N, 6.25%.
3.2. [Zn(OAc)2(NHC)]2 (2)
Zn(OAc)2 (183.5 mg, 1.000 mmol) was suspended in
15 ml of THF and a solution of 1,3-bis(2,4,6-trimeth-
ylphenyl)-imidazol-2-ylidene (304.4 mg, 1.000 mmol) in
3 ml THF was added dropwise. Then the mixture was
stirred overnight at room temperature. The solution was
then concentrated to ꢂ5 ml, ca. 10 ml of pentane were
added resulting in the formation of a white precipitate.
It was filtered off, washed three times with pentane, and
dried in vacuo. Yield: 292 mg (60%). FT-IR (ATR-
mode, cmꢁ1): 3050m, 2920m, 1580s, 1486s; H NMR
1
(CDCl3) d 7.19 (2H, s), 7.00 (4H, s), 2.35 (6H, s), 2.10
(12H, s), 1.72 (6H, br); 13C NMR (CDCl3) d 179.15,
173.46, 139.66, 135.25, 134.06, 129.02, 123.17, 22.65,
21.02, 17.24. Anal. Calc. for C25H30N2O4Zn: C, 61.54;
H, 6.20; N, 5.74. Found: C, 61.32; H, 6.01; N, 5.73%.
MS (FAB): m=z calc. for C25H30N2O4Zn: 486.15, found
m=z ¼ 1007:06 (C53H60N5O7Zn2, 73.4%).
3.5. Zn(OSO2CF3)(NHC) (5)
A solution of AgOSO2CF3 (358.3 mg, 1.394 mmol) in
3 ml of THF was added slowly to a solution of 1 (309.4
mg, 0.6973 mmol) in 7 ml of THF. A white solid pre-
cipitated immediately. The mixture was stirred for 2 h at
room temperature, then it was filtered. The filtrate was
concentrated to ꢂ5 ml, after the addition of 20 ml
pentane, a white solid precipitated, which was filtered
off, washed three times with pentane and dried in vacuo.
Yield: 430 mg (83%). Crystals of 5 were obtained by
slowly diffusion of pentane to a concentrated THF so-
lution of the complex. IR (ATR-mode, cmꢁ1): 3121m,
3.3. [Zn(OCOPh)2(NHC)]2 (3)
Zn(OCOPh)2 (44.0 mg, 0.298 mmol, prepared by the
reaction of ZnEt2 and PhCOOH in THF and used
without further purification) was suspended in 10 ml of
THF, then a solution of 1,3-bis(2,4,6-trimethylphenyl)-
imidazol-2-ylidene (43.5 mg, 0.299 mmol) in 2 ml of
THF was added. After 20 min of stirring, the precipitate
had dissolved. The mixture was stirred overnight, and
was then concentrated to ca. 2 ml. Ten milliliters of
pentane was added and the mixture was cooled to )40
°C. A white solid formed after 2 days, which was filtered
off, washed with pentane, and dried in vacuo. Yield: 52.5
mg (60%). FT-IR (ATR-mode, cmꢁ1): 3025m, 2914m,
1636s, 1585w, 1367s, 850s. 1H NMR (CDCl3) d 7.77
(4H, t, J ¼ 6:93), 7.37 (2H, t, J ¼ 6:93), 7.26 (4H, t,
1
2921m, 1610m, 1486m, 1320s, 1201w, 1009s; H NMR
(CDCl3) d 7.24 (2H, s), 7.03 (4H, s), 3.63 (4H, t), 2.33
(6H, s), 2.09 (12H, s), 1.75 (4H, m); 13C NMR (CDCl3) d
166.85, 140.86, 134.81, 133.00, 130.0, 129.66, 125.38,
121.16, 116.95, 112.74, 69.64, 25.19, 21.03, 17.22.
3.6. {[R(+)-a-2-(1-phenylethylimino)-methyl]-phenol}
(6a)
Salicyaldehyde (3.05 g, 25.0 mmol) and R(+)-a-
methylbenzylamine (3.03 g, 25.0 mmol) were dissolved